Clinical trials
Phase 2/3 trials in Austria with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Vienna | 5 |
| Ethicare GmbH | 3 |
| Alloksys Life Sciences B.V. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Gilead Sciences | 1 |
| International Biomedical Systems S.p.A. | 1 |
| Medical University of Graz | 1 |
| Prim. Prof. Dr. Oliver Findl, MBA | 1 |
| ProFem GmbH | 1 |
| The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 3 |
| Cardiomyopathy, Dilated | 2 |
| Heart Defects, Congenital | 2 |
| Aortic Aneurysm, Abdominal | 1 |
| Atherosclerosis | 1 |
| Burkitt Lymphoma | 1 |
| COVID-19 | 1 |
| Candidiasis, Vulvovaginal | 1 |
| Carcinoma, Embryonal | 1 |
| Central Serous Chorioretinopathy | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.